SHENZHEN, China I 14, 2025 I Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) ...

AIM ImmunoTech (AIM) announced its initiation of a plan to advance Ampligen as a vaccine adjuvant for avian influenza as part of the Company’s ...

Investing.com -- AIM ImmunoTech (NYSE: AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...

BMO Capital Markets managing director Evan Seigerman sits down with Seana Smith and Brad Smith on the Morning Brief to speak about AbbVie's drug research and product pipeline, especially as sales ...

announces today the publication of an invited review of the preclinical and clinical development of INNA-051 in Antiviral Research, a monthly peer-reviewed medical journal of the International Society ...

announces today the publication of an invited review of the preclinical and clinical development of INNA-051 in Antiviral Research, a monthly peer-reviewed medical journal of the International ...

Hit Rates & One-Shot Approach: All 12 compounds in the NCE library discovered by GALILEO TM using a One-Shot approach, from the 50T compound solution space, exhibited antiviral activity ... potential ...